Data completeness
1/8 — Limited
Drug data last refreshed 2h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SOY-DOME is a topical emulsion formulation of hexachlorophene, an antimicrobial agent used to reduce bacterial colonization on skin surfaces. The drug works through broad-spectrum antimicrobial activity, inhibiting bacterial growth on application sites. It is a non-biologic small molecule therapeutic in pre-launch stage under NDA review by R-Pharm US.
Pre-Launch
Early-stage launch environment with undefined market trajectory; commercial infrastructure still being built by R-Pharm US with limited public hiring signal.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Why This Matters for Your Career
R-Pharm US is hiring 4 roles related to this product
Worked on SOY-DOME at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.